Mads N Holten-Andersen

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi request reprint Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay
    M N Holten-Andersen
    Institute for Pharmacology and Pathobiology, The Royal Veterinary and Agricultural University, Frederiksberg C, Copenhagen, Denmark
    Int J Biol Markers 18:170-6. 2003
  2. ncbi request reprint Plasma TIMP-1 in patients with colorectal adenomas: a prospective study
    Mads N Holten-Andersen
    Department of Pharmacology and Pathobiology, The Royal Veterinary and Agricultural University, Ridebanevej 9, 1870 Frederiksberg, Denmark
    Eur J Cancer 40:2159-64. 2004
  3. ncbi request reprint Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer
    M N Holten-Andersen
    Department of Veterinary Pathology, The Veterinary University, Frederiksberg
    Int J Biol Markers 21:6-11. 2006
  4. ncbi request reprint Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer
    Mads Nikolaj Holten-Andersen
    The Institute of Veterinary Patobiology, The Royal Veterinary and Agricultural University, Ridebanevej 9, 1870 Frederiksberg, Denmark
    Eur J Cancer 42:1889-96. 2006
  5. doi request reprint [An 11-month-year-old girl with repeated respiratory infections]
    Mads N Holten-Andersen
    Barneavdelingen, Sykehuset Innlandet Lillehammer, 2619 Lillehammer, Norway
    Tidsskr Nor Laegeforen 130:846-8. 2010
  6. ncbi request reprint Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer
    Anne Sofie Schrohl
    The Royal Veterinary and Agricultural University, Department of Pharmacology and Pathobiology, Frederiksberg C, Denmark
    Clin Cancer Res 10:2289-98. 2004
  7. ncbi request reprint Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism
    Morten Krogh Jensen
    Department of Haematology L, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
    Eur J Haematol 71:276-82. 2003
  8. ncbi request reprint Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer
    Anne Sofie Schrohl
    Department of Veterinary Pathobiology, The Royal Veterinary and Agricultural University, Frederiksberg C, Denmark
    Clin Cancer Res 12:7054-8. 2006
  9. ncbi request reprint Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer
    Anne Sofie Schrohl
    The Finsen Laboratory, Rigshospitalet dept 8621, Strandboulevarden 49, DK 2100 Copenhagen, Denmark
    Mol Cell Proteomics 2:164-72. 2003

Detail Information

Publications9

  1. ncbi request reprint Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay
    M N Holten-Andersen
    Institute for Pharmacology and Pathobiology, The Royal Veterinary and Agricultural University, Frederiksberg C, Copenhagen, Denmark
    Int J Biol Markers 18:170-6. 2003
    ..The possible effect of preanalytical conditions such as blood sample preparation and handling on TIMP-1 levels in blood needs thorough investigation...
  2. ncbi request reprint Plasma TIMP-1 in patients with colorectal adenomas: a prospective study
    Mads N Holten-Andersen
    Department of Pharmacology and Pathobiology, The Royal Veterinary and Agricultural University, Ridebanevej 9, 1870 Frederiksberg, Denmark
    Eur J Cancer 40:2159-64. 2004
    ..02). The present study demonstrates that measurement of plasma TIMP-1 cannot be used for the identification of adenomatous or hyperplastic polyps of the large intestine...
  3. ncbi request reprint Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer
    M N Holten-Andersen
    Department of Veterinary Pathology, The Veterinary University, Frederiksberg
    Int J Biol Markers 21:6-11. 2006
    ..To assess the potential use of plasma and urine levels of tissue inhibitor of metalloproteinases 1 (TIMP-1) in urothelial cancer...
  4. ncbi request reprint Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer
    Mads Nikolaj Holten-Andersen
    The Institute of Veterinary Patobiology, The Royal Veterinary and Agricultural University, Ridebanevej 9, 1870 Frederiksberg, Denmark
    Eur J Cancer 42:1889-96. 2006
    ..0001). In conclusion, postoperative plasma TIMP-1 predicts patient outcome both alone and in combination with CEA. Postoperative TIMP-1 may be a marker of residual disease after primary surgery for CRC...
  5. doi request reprint [An 11-month-year-old girl with repeated respiratory infections]
    Mads N Holten-Andersen
    Barneavdelingen, Sykehuset Innlandet Lillehammer, 2619 Lillehammer, Norway
    Tidsskr Nor Laegeforen 130:846-8. 2010
    ..We also discuss specific treatment of ventricular non-compaction and briefly report on children with non-compaction at the largest pediatric cardiology centre in Norway...
  6. ncbi request reprint Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer
    Anne Sofie Schrohl
    The Royal Veterinary and Agricultural University, Department of Pharmacology and Pathobiology, Frederiksberg C, Denmark
    Clin Cancer Res 10:2289-98. 2004
    ....
  7. ncbi request reprint Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism
    Morten Krogh Jensen
    Department of Haematology L, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
    Eur J Haematol 71:276-82. 2003
    ..Plasma levels of MMP-2 and -9 were not correlated to serum markers for collagen metabolism. These findings suggest that enzymes of the uPA system might participate in the bone marrow remodelling processes characteristic of MPD...
  8. ncbi request reprint Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer
    Anne Sofie Schrohl
    Department of Veterinary Pathobiology, The Royal Veterinary and Agricultural University, Frederiksberg C, Denmark
    Clin Cancer Res 12:7054-8. 2006
    ....
  9. ncbi request reprint Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer
    Anne Sofie Schrohl
    The Finsen Laboratory, Rigshospitalet dept 8621, Strandboulevarden 49, DK 2100 Copenhagen, Denmark
    Mol Cell Proteomics 2:164-72. 2003
    ..Furthermore TIMP-1 adds prognostic information to that obtained from PAI-1. However, further validation in independent data sets is needed...